| Alexandra B Kiefer, MD | |
|
101 Nicolls R Obgyn Dept Hsc Level 9, Stony Brook, NY 11794-0001 | |
| (631) 444-4686 | |
| Not Available |
| Full Name | Alexandra B Kiefer |
|---|---|
| Gender | Female |
| Speciality | Obstetrics & Gynecology |
| Location | 101 Nicolls R Obgyn Dept Hsc Level 9, Stony Brook, New York |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1689107641 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | 315865 (New York) | Primary |
| Entity Name | University Associates In Obstetrics & Gynecology University Faculty P |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1538114723 PECOS PAC ID: 9032001045 Enrollment ID: O20040325001243 |
News Archive
The "switching on" or expression of specific genes in the human genome is what makes each human tissue and each human being unique. A new study by researchers at the Johns Hopkins Bloomberg School of Public Health, the Lieber Institute for Brain Development, and the National Institute of Mental Health found that many gene expression changes that occur during fetal development are reversed immediately after birth.
The U.S. Food and Drug Administration today issued two comprehensive evaluations containing recommendations that address three key objectives of the agency's public health mission as it relates to medical devices – foster device innovation, create a more predictable regulatory environment, and enhance device safety.
The recent approval of Merck & Co.'s Keytruda by the U.S. Food and Drug Administration for the treatment of malignant melanoma is a significant milestone for Merck & Co. and for the oncology immunotherapy drug market. Decision Resources Group anticipates the launch of Keytruda as the first anti-PD-1 immunotherapy in the United States for treatment of advanced and unresectable malignant melanoma.
"So sue me" is President Obama's message to Congress. And on Wednesday the House of Representatives took up his taunt, authorizing a lawsuit to challenge the president's failure to faithfully execute provisions of the Affordable Care Act as passed by Congress. The House lawsuit is no "stunt," as Mr. Obama has characterized it.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Alexandra B Kiefer, MD 101 Nicolls R Obgyn Dept Hsc Level 9, Stony Brook, NY 11794-0001 Ph: (631) 444-4686 | Alexandra B Kiefer, MD 101 Nicolls R Obgyn Dept Hsc Level 9, Stony Brook, NY 11794-0001 Ph: (631) 444-4686 |
News Archive
The "switching on" or expression of specific genes in the human genome is what makes each human tissue and each human being unique. A new study by researchers at the Johns Hopkins Bloomberg School of Public Health, the Lieber Institute for Brain Development, and the National Institute of Mental Health found that many gene expression changes that occur during fetal development are reversed immediately after birth.
The U.S. Food and Drug Administration today issued two comprehensive evaluations containing recommendations that address three key objectives of the agency's public health mission as it relates to medical devices – foster device innovation, create a more predictable regulatory environment, and enhance device safety.
The recent approval of Merck & Co.'s Keytruda by the U.S. Food and Drug Administration for the treatment of malignant melanoma is a significant milestone for Merck & Co. and for the oncology immunotherapy drug market. Decision Resources Group anticipates the launch of Keytruda as the first anti-PD-1 immunotherapy in the United States for treatment of advanced and unresectable malignant melanoma.
"So sue me" is President Obama's message to Congress. And on Wednesday the House of Representatives took up his taunt, authorizing a lawsuit to challenge the president's failure to faithfully execute provisions of the Affordable Care Act as passed by Congress. The House lawsuit is no "stunt," as Mr. Obama has characterized it.
› Verified 7 days ago
Noel Omar Mohammed, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 1 Stadium Rd., Stony Brook University Student Health Service, Stony Brook, NY 11790 Phone: 631-632-6740 | |
Dr. Michael L. Pearl, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: Hsc 9th Fl. Rm 065, Stony Brook University Hospital, Stony Brook, NY 11790 Phone: 631-444-6907 | |
Dr. Andre Plair, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: Stony Brook University Medical Ctr, Department Of Ob/gyn, Hsc, T9, Stony Brook, NY 11794 Phone: 631-444-4686 Fax: 631-444-4622 | |
Scott Berman, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 2500 Nesconset Hwy, Building 12 Suite 45, Stony Brook, NY 11790 Phone: 631-675-9010 Fax: 631-675-9009 | |
Dr. Christian P Westermann, M.D. Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 2500 Route 347, Building 19c, Suite 72, Stony Brook, NY 11790 Phone: 631-751-9700 Fax: 631-751-6979 | |
Nicole Lynn Massad, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 101 Nicolls Rd, Stony Brook, NY 11794 Phone: 631-689-8333 | |
Dr. Diana Calero-kunda, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 101 Nicolls Road Hsc Level 9 Rm 090, Stony Brook, NY 11794 Phone: 631-444-2757 Fax: 631-444-6155 |